Safety and Effectiveness of Bone Marrow Cell Concentrate in the Treatment of Chronic Critical Limb Ischemia Utilizing a Rapid Point-of-Care System

<div>(a) Analysis of change in ABI using two imputation methods: “0” imputation and LOCF. (b) Analysis of change in TcPO<sub>2</sub> using two imputation methods: “0” imputation and LOCF.</div>

Stem Cells International

fig3

Figure 3

Figure 3: Safety and Effectiveness of Bone Marrow Cell Concentrate in the Treatment of Chronic Critical Limb Ischemia Utilizing a Rapid Point-of-Care System 

Figure 3 | Safety and Effectiveness of Bone Marrow Cell Concentrate in the Treatment of Chronic Critical Limb Ischemia Utilizing a Rapid Point-of-Care System 